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Abstract
Background: Elevation of intracranial pressure in idiopathic intracranial hypertension induces an edema of the
prelaminar section of the optic nerve (papilledema). Beside the commonly observed optic nerve sheath distention,
information on a potential pathology of the retrolaminar section of the optic nerve and the short-term effect of
normalization of intracranial pressure on these abnormalities remains scarce.
Methods: In this exploratory study 8 patients diagnosed with idiopathic intracranial hypertension underwent a MRI
scan (T2 mapping) as well as a diffusion tensor imaging analysis (fractional anisotropy and mean diffusivity). In
addition, the clinical presentation of headache and its accompanying symptoms were assessed. Intracranial pressure
was then normalized by lumbar puncture and the initial parameters (MRI and clinical features) were re-assessed
within 26 h.
Results: After normalization of CSF pressure, the morphometric MRI scans of the optic nerve and optic nerve
sheath remained unchanged. In the diffusion tensor imaging, the fractional anisotropy value was reduced
suggesting a tissue decompression of the optic nerve after lumbar puncture. In line with these finding, headache
and most of the accompanying symptoms also improved or remitted within that short time frame.
Conclusion: The findings support the hypothesis that the elevation of intracranial pressure induces a
microstructural compression of the optic nerve impairing axoplasmic flow and thereby causing the prelaminar
papilledema. The microstructural compression of the optic nerve as well as the clinical symptoms improve within
hours of normalization of intracranial pressure.
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Introduction
Idiopathic intracranial hypertension (IIH) is defined as an
elevation of intracranial pressure (ICP) without hydroceph-
alus or mass lesion and with normal CSF composition [1].
Currently the incidence is estimated at 0.03–2.36 cases per
100,000 of the general population [2–7] but it may be as-
sumed that this figure will increase over the next decades
as the disorder occurs mainly in obese women and the
prevalence of obesity is increasing worldwide from year to
year [8, 9]. The clinical picture of IIH is mainly character-
ized by a rather unspecific and highly variable headache
[10] and visual deficits which result mainly from a
pressure-induced papilledema [10–19]. While these symp-
toms are the main reasons for patients to seek medical ad-
vice, other symptoms such as cranial nerve palsies [20–24],
olfactory disturbances [25–28] and cognitive impairment
[29–32] may occur.
Visual alterations are observed in the vast majority of IIH
patients [12, 33–35] but even so, the detailed mechanisms
underlying this functional deficit remain far from being en-
tirely understood. It may seem obvious that the elevation of
ICP induces papilledema which in turn causes visual deteri-
oration. However, there are many questions that remain
unanswered. For example, it remains unclear if the
pressure-induced changes affect exclusively the papilla of
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the optic nerve (ON) or if other regions along the visual
pathway may be affected as well. It may be assumed that
beyond the significant abnormalities observed in the papil-
lar region, the ON suffers pressure-induced microstructural
alterations in its myelinated retrobulbar segment [36] but it
remains unclear if they are the direct consequence of ele-
vated CSF pressure. In this context it is not known if and in
which time frame these abnormalities would reverse upon
a pressure relief obtained by a lumbar puncture. This aspect
is particularly important as it is still unknown how long it
takes to develop a papilledema after the increase of ICP.
However, given its pathomechanism it is commonly ac-
cepted that the development does not occur immediately
but requires a certain amount of time to develop upon an
elevation of ICP [37, 38]. This delay suggests, that either an
elevation of ICP does not immediately lead to an increase
in pressure in the CSF space surrounding the ON or that
additional mechanisms that go beyond the direct
pressure-induced effects complement the functional
changes that lead to visual deterioration. This hypothesis is
supported by the observations that IIH-associated head-
ache does not correlate to ICP [39, 40], papilledema [41] or
any other IIH-related symptom [30] and that pressure re-
lief does not induce a long-term remission of the head pain
in the majority of patients [10, 42]. However, even in re-
gard to the assumed short-term benefit of pressure-relief,
objective data is limited. This is particularly the case for
symptoms that may accompany IIH-related headache, such
as nausea, photo- and phonophobia as well as tinnitus.
These symptoms seem less significant at first, but in fact
they may hamper the early diagnosis of IIH as they can
lead the clinician to a misdiagnosis due to the clinical simi-
larity to other headaches such as migraine [10, 11].
Quantitative diffusion tensor imaging (DTI) has been
used to investigate various white matter diseases in vivo. It
was shown that DTI is sensitive enough to detect axonal
degeneration in rat glaucoma model [43] or the wallerian
degeneration in acquired blindness [44] or to demonstrate
pre- and post-chiasmatic diffusion tensor abnormalities in
children with septo-optic dysplasia [45].
The aims of the present study were twofold. First, we
sought to investigate if microstructural patterns within the
ON may be affected by normalization of CSF pressure
using state-of-the-art DTI magnetic resonance (MR) tech-
niques. Secondly, we aimed at dissecting the characteris-
tics of IIH-related headache and its accompanying
symptoms as well as to analyze a potential improvement
after the reduction of CSF opening pressure.
Methods
The study was approved by the local ethics committee of
the Charité - Universitätsmedizin Berlin (EA1/005/15). All
patients participating in the study provided written in-
formed consent. MRI measurements were performed
between Feb. 11, 2015 and Nov. 25, 2015. Patients re-
ceived two MRI scans during the study, one prior to the
lumbar puncture and the second within 26 h (mean 15,54
h) after the lumbar puncture. In several of the cases the
lumbar puncture in the study was not the diagnostic
puncture, but all patients had no lumbar puncture within
the last six months. Beyond the effect on microstructural
alterations of the ON, changes of accompanying symp-
toms such as nausea, photo-, phono-, osmophobia and tri-
geminoautonomic symptoms were evaluated within that
time frame.
Patients
Eight patients of Caucasian descent (one male, seven fe-
male, mean age: 39,4 ± 3,7 years, BMI: 34,9 ± 1,5 kg/m2)
diagnosed before with IIH according to the revised criteria
established by Friedman et al. [1] were included in the
study. Time of IIH diagnosis was within the last 18
months. Exclusion criteria included any medical condi-
tions, IIH specific medications, surgical procedure that
may affect ICP, significant weight loss or lumbar puncture
within the last six months. IIH-associated headache was
diagnosed according to the diagnostic criteria established
by the International Headache Society (ICHD3 beta) [46].
MR imaging (MRI)
MRI was performed on a 1.5 T scanner (Siemens Avanto
Magnetom, Erlangen, Germany). In addition to the cir-
cularly polarized head coil, a loop surface coil (7 cm
diameter) was placed and fixed over the most affected
eye according to visual field defects based on the oph-
thalmological examination. For the evaluation of the ON
and the optic nerve sheath (ONS) a coronal turbo spin
echo (TSE) sequence was used (repetition time [TR]
6960 msec, echo time [TE] 99 msec, field of view [FOV]
85 × 85mm2, matrix size of 256 × 256 [in plane reso-
lution 0.332 × 0.332 mm2], slice thickness 2 mm and ac-
quisition time [TA] 7 min 20 s). DTI images were
acquired through a single-shot echo planar (EPI) se-
quence in axial orientation (TR 5448 msec, TE 88msec,
FOV of 192 × 192mm2, matrix size of 128 × 128 [in
plane resolution 1.5 × 1.5 mm2], slice thickness 3 mm,
TA 11min 44 s). The diffusion weighting (b value) was
set to 0 and 1000 s mm− 2. Images were acquired with
diffusion gradients in 126 directions with a number of
acquisitions of 6, comprising 41 slices covering the
whole brain. For the assessment of sinus vein stenoses
(SVS) and the exclusion of sinus vein thrombosis (SVT)
as secondary causes of intracranial hypertension, a 2D
time-of-flight (2D TOF) venography (TR 23msec, TE
6.5 msec, FOV 250 × 250 mm2, matrix size 512 × 512 [in
plane resolution 0.488 × 0.488 mm2], slice thickness 2
mm, TA 7min 40 s) was performed.
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Morphometric analysis
To allow a correlation between macroscopic findings and
potential microscopic alterations, maximum ONS and
ON diameters were measured in the most affected eye on
coronal T2w images perpendicular to the ON in the slice
with the maximum ONS diameter (Fig. 1a) measured with
a MR microscopy surface coil. MRIs were evaluated by a
neuroradiologist and a neurologist (E.W., J.H.) in a blinded
fashion. To test the interrater agreement, we have calcu-
lated Crohnbach’s alpha for the ON diameter and for the
FA values.
MR-tractography
The MRI data has been denoised, corrected for eddy cur-
rents and motion and underwent a bias field correction
for tractography purposes [47–49]. Probabilistic tractogra-
phy has been performed with the iFOD2 algorithm and by
using a seeding and an inclusion spherical region of inter-
est (ROI) at the anterior and posterior positions of the
optic nerves [50]. The iFOD2 is a probabilistic algorithm
that takes Constrained Spherical Deconvolution (CSD)-es-
timated fiber orientation distribution (FOD) fields as in-
put. Tracking parameters were set to default with a FOD
amplitude cutoff value of 0.05, a streamline minimum
length of 5 x voxelsize and a maximum streamline length
of 100 x voxelsize.
The depicted image shows 5000 streamlines delineat-
ing a patients left and right optic nerves (Fig. 1c).
DTI analysis
DTI data were corrected for eddy current distortion and
motion and underwent a bias field correction for tracto-
graphy purposes [47–49]. DTI data were converted from
DICOM into NIFTI format using the DICOM to NIFTI
format converter dcm2nii (Dicom office toolkit DCMTK,
https://dicom.offis.de/, Oldenburg, Germany). Voxelwise
statistical analyses of fractional anisotropy (FA) and mean
diffusivity (MD) data were performed using FSL 4.1.8
(FMRIB Software Library, Oxford, UK) [48, 51, 52]. The b0
data were used for brain segmentation using BET (Brain
Extraction) [53]. For the segmentation of white and grey
matter an automatic segmentation tool (FAST) was used.
FA and MD values were calculated by reconstruction of dif-
fusion tensors using FDT (FMRIB’s Diffusion Toolbox) and
DTIFIT. Subjects’ FA and MD data were adjusted into an
1x1x1 mm standard space using tract-based spatial statistics
(TBSS) [54] with FNIRT (FMRIB’s nonlinear registration
tool), which uses a b-spline representation of the registra-
tion warp field [55]. For ROI analysis of the optic pathway,
optic nerve and optic tract were outlined manually on
MPRAGE and transferred to coregistered FA and MD im-
ages using Amira 5.3.2 (Visage Imaging Inc., San Diego,
CA, USA) [56] (Fig. 1c).
T2 analysis
T2 mapping (TR 3100ms, TE 13,8ms - 165,6 ms with
twelve TEs: 13,8ms, 27,6ms, 41,4ms, 55,2ms, 69ms,
82,2ms, 96,6ms, 110,4ms, 124,2ms, 138ms, 151,8 ms,
165,6 ms). T2 maps were online reconstructed by using a
voxelwise, monoexponential nonnegative least-squares fit
analysis (MapIt; Siemens, Erlangen, Germany) with a
voxel size of 1.9 × 1.0 × 3mm3. A ROI was manually delin-
eated around the optic nerve on the T2 maps (Fig. 1b).
Statistical analysis
Statistical analysis was performed using XLSTAT Version
2016.5 (Addinsoft SARL, New York, NY, USA). Normality
of the data was calculated using the Shapiro-Wilk test. For
the comparison of group means, the Mann-Whitney
U-Test was used and data were expressed as median with
5th and 95th percentiles. Statistical significance was as-
sumed at p < 0.05. To estimate the strength of the param-
eters Pearson’s correlation coefficient and correlation
matrices were calculated. Crohnbach’s alpha was used to
test for interrater variability.
Fig. 1 a shows an example of a coronal T2w image of the ON and ONS on which ON and ONS diameters where calculated. b shows the coronal
T2-mapping. c illustrates the DTI measurements of the ON and depicts an MR-tractography of the ON
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Results
Morphometric analysis
The morphometric analysis revealed that CSF pressure
reduction through lumbar puncture does not affect me-
dian ON and ONS diameters of IIH patients within the
investigated time frame (ON p = 0.130, ONS p = 0.798)
(Table 1, Fig. 1). Crohnbach’s alpha for the ON diameter
was α = 0.72 which is accurate according to the small pa-
tient number.
DTI analysis
Compared to the baseline measurement, FA values of
the optic nerve were significantly reduced after lumbar
puncture (p = 0.038) (Fig 2). In contrast, analysis of the
MD values of the optic nerve remained unaffected by
lumbar puncture (p = 0.382) (Table 1). Crohnbach’s
alpha for the FA values was α = 0.48 which is acceptable
according to the small patient number.
T2 analysis
The comparison of the T2 value of the ON before and
after lumbar puncture revealed no significant difference
(p = 0.310) (Table 1, Fig. 3).
Clinical assessment
The influence on clinical parameters was assessed in the
same time frame. At the initial assessment seven out of
eight patients (87,5%) presented with headache. Of those
patients reporting headache, mean pain intensity, as
assessed on a verbal analog scale ranging from zero to
Fig. 2 Illustrates the variation in the FA a and MD b values prior and after normalization of CSF pressure through lumbar puncture. The FA value
was significantly reduced after normalization of CSF pressure (p = 0.038)
Fig. 3 Illustrates the changes in ON a and ONS b diameters as well as in T2 values c before and after normalization of CSF pressure. The
normalization of CSF pressure did not induce a significant change in any of the three parameters (ON p = 0.130, ONS p = 0.798, T2 p = 0.310)
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ten, was 2,94 ± 1,02. As outlined in Table 2, the majority
of the patients had at least one accompanying symptom
typically found in migraine, such as nausea, photo-,
phono- and osmophobia, and slightly over a third of the
patients had trigeminoautonomic symptoms such as lac-
rimation or rhinorrhea. With the exception of photopho-
bia, which remitted in half of the patients after lumbar
puncture, all the other accompanying symptoms includ-
ing the trigeminoautonomic symptoms remitted com-
pletely within the observed time frame. The detailed
description of accompanying symptoms as well as their
development after lumbar puncture are listed in Table 2.
Following the initial assessment and the first MRI scan
all patients underwent a fluoroscopically guided lumbar
puncture (E.W.) and CSF opening pressures were mea-
sured in the lateral decubitus position. The mean CSF
pressure at baseline was 31,00 ± 2,20 cm CSF and was re-
duced to 12,19 ± 1,06 cm CSF. In the average 24ml ± 4.8
ml of CSF were withdrawn. After lumbar puncture a sec-
ond MRI scan and a reassessment of the clinical findings
(headache and accompanying symptoms) was performed
within 26 h. Following normalization of intracranial
pressure headache severity improved in over 60% and
photophobia in 50% of the patients. If nausea, phono-
phobia, osmophobia and/or trigeminoautonomic
symptoms were present at baseline, these symptoms
remitted completely in all of the affected patients
within the observation period of 26 h (Table 2). In
line with these findings, 50% of patients suffered from
tinnitus at baseline and in all affected patients, symp-
toms remitted after lumbar puncture (Table 2).
Correlation of imaging parameters with clinical
parameters
The change of the headache intensity before and after
lumbar puncture did not correlate with the change in
the FA values of the optic nerve (r = − 0.626, p = 0.097)
(Fig. 4) or with the change of the T2 values measured of
the optic nerve (r = − 0.754; p = 0.084). Furthermore, no
correlations were observed between the difference of
CSF pressure before and after lumbar puncture with the
change of the FA (r = 0.323; p = 0.435) (Fig. 4) and T2
values (r = − 0.314, p = 0.544) of the optic nerve.
Fig. 4 Depicts the correlations between the difference in FA value and CSF pressure a as well as between the difference of FA values and
headache intensity b before and after normalization of CSF pressure. In both cases correlations were not significant (p > 0.05)
Table 1 Summarizes the changes that normalization of CSF pressure induced on several morphometric and DTI measurements
Pre-LP Post-LP Significance
CSF opening pressure [cm H2O] 28.50 [26.00; 43.00] 12.00 [7.00; 17.00] p < 0.0001
FA 0.309 [0.271; 0.354] 0.259 [0.218; 0.339] p = 0.038
MD 0.0012 [0.0001; 0.0013] 0.0013 [0.0001; 0.0014] p = 0.382
ON diameter [mm] 2.95 [2.70; 3.00] 3.00 [2.80; 3.20] p = 0.130
ONS diameter [mm] 5.00 [4.50; 6.90] 4.95 [4.50; 7.40] p = 0.798
T2 [ms] 90.89 [59.00; 211.41] 114.44 [89.25; 177.81] p = 0.310
Data are expressed as median with 5th and 95th percentile. Statistical analysis was performed using the non-parametric Mann-Whitney U-Test and significance
was assumed at p < 0.05
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Discussion
In the present study we have shown in IIH patients that a
reduction of ICP through a lumbar puncture does not in-
duce a reduction of the ON and ONS diameters within the
short time frame of 26 h. Furthermore, the DTI analysis of
the ON revealed that the reduction in CSF pressure in-
duced a decrease in the FA value reflecting a reduced re-
striction of the directionality of molecular diffusion. In
contrast MD values remained unaffected after lumbar
puncture as were the T2 values, indicating that the dysfunc-
tion of the ON is unlikely to involve an edematous process.
Neuroimaging techniques and in particular MRI are
an essential component of the diagnostic workup of IIH
to exclude secondary causes and to identify typical mor-
phometric alterations commonly observed in IIH [1, 15,
18]. These alterations include the empty sella, a disten-
sion of the ONS (perioptic subarachnoid space) and a
flattening of the posterior aspect of the optic globe [1,
39, 40]. The time lag between the initiation of the eleva-
tion of ICP and the establishment of these structural al-
terations remains unclear [37]. Perhaps even more
important from a clinical perspective is the potential re-
versibility of these findings after normalization of ICP.
However, if some or all of the abnormalities observed in
the MRI improve after normalization of intracranial pres-
sure is still debated. While an increasing number of publi-
cations report an improvement, in particular of the
transverse sinus stenoses [57, 58], structured prospective
studies addressing this question remain scarce and in re-
gard to the ON and the ONS such studies, to the best of
our knowledge, do not exist at all.
The present study investigated the IIH-related alter-
ations of the ON and the ONS as well as their develop-
ment after normalization of ICP using a loop surface coil
on the orbita allowing the acquisition of high-resolution
images of these structures.
The findings of our study indicate that the normalization
of ICP does not have a short-term effect on morphological
alterations of the ON. In contrast, the alteration of the FA
value seen in the DTI suggests that elevated ICP affects
microstructural integrity of the ON as the pressure-induced
compression of the ON tissue leads to an increase in the
directionality of molecular diffusion, a consequence that is
reversed within hours of pressure relief. It may be specu-
lated that the compression of the optic nerve as such and
its microstructural consequences could add to the func-
tional visual deficit induced by the papilledema, which is in-
duced by a pressure-induced decrease in axoplasmic flow,
but the answering of this question was beyond the scope of
our study. The fact that we did not observe an alteration in
the MD value of the ON supports the current pathophysio-
logical concept that the pressure-induced edema is limited
to the prelaminar part of the ON head [37, 59], which is lo-
cated in front of the lamina cribrosa, and the adjacent ret-
ina [37], without affecting the postlaminar myelinated
section of the ON [60].
Physiological axoplasmic flow depends on an intraaxonal
pressure gradient between the ocular portion (maintained
by intraocular pressure) and the extraocular portion (main-
tained by the pressure of the ON tissue) of the ON. The
elevation of intracranial and ONS CSF pressure causes an
increase of the retrolaminar tissue pressure that is reflected
in the observations we made in the DTI of the ON. The el-
evated tissue pressure results in an imbalance of the
intraaxonal pressure gradient that affects axoplasmic flow
leading to an axoplasmic flow stasis in the ON head and a
papilledema. Axoplasmic stasis leads to a swelling of the
ON head and optic disc swelling that, if untreated, result in
retinal hemorrhages and ischemia and finally to optic disc
atrophy. This pathomechanism, the slow velocity of the
axoplasmic flow and therefore the time needed to create an
axoplasmic stasis and edema upon mechanical obstruction
as well as the narrow capillary CSF communication in the
optic canal explain the delay between the elevation of intra-
cranial pressure and papilledema and why these changes
are only observed in chronic but not in acute elevations of
intracranial pressure [61].
Table 2 Summarizes the characteristics of the study population
as well as the characteristics of IIH-related headache and its
accompanying features prior and after normalization of CSF
pressure
Patient data
Age [a] 39.4 y ± 3.70
Sex [M:F] 1:7
BMI [kg/m2] 34.90 ± 1.50
Volume CSF [ml] 23.38 ± 1.70
Clinical data
Headache intensity before LP [x/10] 2.94 ± 1.02
Headache intensity after LP [x/10] 0.56 ± 0.32
Photophobia before LP [%] 50.00 (4/8 pat.)
Photophobia after LP [%] 25.00 (2/8 pat.)
Phonophobia before LP [%] 37.50 (3/8 pat.)
Phonophobia after LP [%] 0.00 (0/8 pat.)
Osmophobia before LP [%] 25.00 (2/8 pat.)
Osmophobia after LP [%] 0.00 (0/8 pat.)
Lacrimation before LP [%] 37.50 (3/8 pat.)
Lacrimation after LP [%] 0.00 (0/8 pat.)
Rhinorrhea before LP [%] 25.00 (2/8 pat.)
Rhinorrhea after LP [%] 0.00 (0/8 pat.)
Nausea before LP [%] 50.00 (4/8 pat.)
Nausea after LP [%] 0.00 (0/8 pat.)
Tinnitus before LP [%] 50.00 (4/8 pat.)
Tinnitus after LP [%] 0.00 (0/8 pat.)
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Until now it remains to be clarified in which time frame
the reduction of intracranial pressure reverses these find-
ings. Studies investigating the effect on normalization of
intracranial pressure on papilledema and visual distur-
bances generally investigate the evolution of these abnor-
malities in longer time frames. For example the NORDIC
trial investigating the effect of acetazolamide assessed
these parameters after 1 month [62]. To the best of our
knowledge no study has investigated prospectively the
short-term effect within hours of pressure normalization
on the retrolaminar, myelinated section of the optic nerve
using MR imaging techniques. However, previous studies
on olfaction in IIH suggested, that the improvement and
therefore the structural abnormalities, may improve
within hours of normalization of ICP [28]. Our study
shows that when tissue pressure on the ON is relieved,
microstructural abnormalities are reversed but morpho-
metric alterations remain unaffected within 26 h (mean
15:54 h) of normalization of ICP. While this seems obvi-
ous at first, it is surprising as the increase in CSF pressure
within the ONS appears with a substantial delay compared
to the intracranial CSF pressure and one would therefore
suspect that upon pressure relief, the distention of the
compressed optic nerve would occur much later.
Beyond the effect of normalization of ICP on micro-
structural alterations of the ON observed in the DTI, most
of the patients presented accompanying symptoms com-
monly seen in migraine such as nausea, photo-, phono-
and osmophobia and some had trigeminoautonomic
symptoms. With the exception of photophobia, all the
other accompanying symptoms remitted completely
within the observed time frame. While the prevalences of
these accompanying symptoms at initial presentation are
similar to those observed by Yri et al. [10, 42], our study
shows that most of these symptoms remit within hours of
normalization of ICP. Interestingly Yri et al. observed that
despite normalization of ICP headache and accompanying
symptoms persist (or return) 1 month after pressure
normalization [10, 11, 42]. Taken together, the findings
suggest that pressure relief induces a short-lasting im-
provement of headache and accompanying symptoms
which is not sustaining in a significant number of patients.
The reasons for this rebound despite a normalization of
ICP remain speculative but could be explained by the pa-
tients’ expectance of an improvement (placebo) as well as
through a persistent sensitization of trigeminal neurons.
In this case, while initially the elevated pressure may suf-
fice to activate these sensitized neurons, this may not be
the case shortly after the sudden fall in intracranial pres-
sure but may return after the activation threshold of tri-
geminal neurons is adjusted to the new conditions.
However, these hypotheses are highly speculative and the
clarification of these mechanisms was beyond the scope of
our study.
Limitations
While the described findings are novel to the field, the
study has a few but significant limitations that need to be
taken into account when interpreting the data. First, the re-
sults of this study are based on 8 IIH patients so that they
are of an exploratory nature and therefore need to be con-
firmed by larger studies. In this context the DTI results are
only slightly significant given the limited amount of patients
in this study. However, considering the exploratory nature
of the study, the rather large error margin that affected the
significance level and the fact that the decrease in the FA
value after lumbar puncture reflects the finding of our pre-
vious study showing an increased FA value in IIH patients
compared to healthy controls [36], suggest that the results
are unlikely to change upon increase of the sample size.
Furthermore, small or negative MRI findings in some pa-
tients on the second MRI scan could be explained with a
faster recovery of intracranial CSF pressure after the lumbar
puncture. Therefore, larger studies are clearly needed to
confirm these findings.
Secondly, the lack of a control group is another
limiting factor. However, as the study required a lum-
bar puncture and two MRI scans within a short time
frame, a healthy control group was not included due
to ethical considerations.
Thirdly, from a methodological perspective, the FA
values provide a measurement that may be the sum of
multiple structures and factors within a voxel. Therefore,
FA values have to be interpreted in relation to anatomy,
pathology and increase in intra- and extracellular water
content. Because of the size differences between the
axons and the voxels it is only possible and to observe
optic nerve microstructure from a macroscopic point of
view with DTI. Furthermore, a single voxel may be com-
posed by fiber populations with different spatial orienta-
tion resulting in an average increase in FA, that is not
due to changes in axonal structure. Therefore, FA is not
always a reliable marker of white matter integrity and
FA values have to be interpreted with caution, in par-
ticular in relation to clinical data [63, 64].
Fourthly, while papilledema was assessed externally by
ophthalmoscopic examination at another campus or by
the referring ophthalmologist to establish the diagnosis
of IIH, we did not re-assess papilledema after lumbar
puncture due to logistical reasons. We therefore had
only the confirmation that patients had a papilledema
but we did not have information on its extent. There-
fore, we could not correlate the alteration of the optic
nerve measured by changes of fractional anisotropy in
relation to the papilledema. Given that this was intended
as an exploratory study this question was beyond its
scope. However, considering the pathomechanism of the
papilledema induced by an elevation of ICP, it is highly
unlikely that the papilledema may improve significantly
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in such a short time frame despite the differences mea-
sured in the optic nerve. In addition, assuming that the
majority of patients had only a mild papilledema we
would expect that our findings would have been more
pronounced with more severe papilledemas or with
higher CSF pressures.
Finally, in respect to the clinical outcome parameters,
a more objective assessment of headache and its impact
on quality of life would have been desirable. However,
given the exploratory nature of the study and the focus-
ing on the short-term effects post-LP we did not have a
longer follow-up period that would have allowed us to
use structured quality of life or disability questionnaires
as these are commonly based on longer observational
periods. However, in that context we would assume that
the clinical improvement we observed post-LP is most
likely of a short-lived nature as other groups have con-
vincingly shown that most IIH patients do not have a
long-term improvement of their headache even if open-
ing pressure is normalized [65].
Conclusion
The findings of our exploratory study show in a DTI ana-
lysis that the microstructural abnormalities, which eleva-
tion of ICP induces within the ON, can be reversed within
26 h of normalization of ICP. In contrast, high-resolution
MRI revealed that morphometric alterations of the retro-
laminar, myelinated section of the ON remain unaffected
by ICP normalization. As alterations in the T2 values of
the morphometric analysis as well as in the MD values of
the DTI analysis were also not observed, we deduce that
the affection of the retrolaminar section of the ON does
not involve an edematous process. Therefore, the
pressure-induced edema appears to be restricted to the
prelaminar optic disc and retina.
The study further suggests, that alterations of the
ON observed in the MRI as well as some clinical fea-
tures of the disorder (headache and accompanying
symptoms) may improve in the hours following
normalization of intracranial pressure. Given the ex-
ploratory nature of this study, further studies are
needed to confirm these findings.
Key findings
Before the study
 visual alterations are observed in the vast majority of
IIH patients
 visual deficits result mainly from a pressure-induced
papilledema
 the underlying mechanisms are only partially
understood
Study adds
 no obvious change in optic nerve T2 values after
withdrawal of CSF
 small changes in fractional anisotropy of the optic
nerve could be observed after lumbar puncture
 after withdrawal of CSF a small distention of the
ON fibers occur
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